The U.S. Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Peninsula Histopathology Laboratory Inc., a minority-owned and for-profit organization, for $4 million. This IDC, which does not have a set-aside designation, is to provide histopathology services to support the VA's Veterans Health Administration and Veterans Integrated Service Network 21 (VISN 21) in northern California. Under this IDC, the VA has issued two significant delivery orders...
The Department of Veterans Affairs' Veterans Health Administration (VA VHA) has awarded a single-award indefinite delivery contract to Iowa Pathology Associates, P.C., a for-profit Subchapter S Corporation based in Des Moines, Iowa. The contract, valued up to $745,002, is to provide on-demand pathology physician services, diagnostic testing, and laboratory services in support of patient care at VA medical centers in the Des Moines region under the VA VHA's Veterans Integrated Service Network 23....
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 21 (VISN 21) awarded a single award indefinite delivery contract (IDC) to Histo-Tec Laboratory, Inc., a self-certified small disadvantaged business, to provide histology slide processing services. The $1.5 million ceiling value IDC has a 5-year period of performance through December 2028 and aims to streamline procurement of these services across the VISN 21 healthcare network....
The U.S. Department of Veterans Affairs (VA), through its Veterans Health Administration's Veterans Integrated Service Network 23 (VHA VISN 23), awarded a single-award indefinite-delivery contract (IDC) to Physicians Laboratory, P.C., doing business as Physicians Laboratory Services, Inc., a for-profit organization. The $6,794,619.50 IDC, awarded in April 2022, has a performance period through March 31, 2027 and provides for the delivery of offsite pathology laboratory testing services to...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 21 (VISN 21) awarded a $2 million Total Small Business set-aside indefinite delivery contract (IDC) to Diagnostic Pathology Medical Group, Inc. (DPMG) in October 2021 to provide recurring histopathology services through September 2024. Under this IDC, the VA VISN 21 has issued firm fixed price delivery orders to DPMG valued at $139,851.14 in 2021, $170,160 in 2022, and $173,640 in...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to South Central Pathology Lab Pa, a minority-owned, woman-owned small business, to provide on-site and off-site pathology services for the Wichita VA Medical Center. The IDC has a ceiling value of $2,575,747.74 and an ultimate completion date of January 6, 2025. Under this IDC, South Central Pathology Lab Pa has been issued a series of annual task orders to deliver pathology testing and...
The key products and services being delivered under this federal contract IDV award are specialized neuropathology testing and associated supplies for the Department of Veterans Affairs (VA). The prime contractor, Therapath Partners LLC, a subsidiary of Inform Diagnostics, Inc., has been awarded two Indefinite Delivery Contracts (IDCs) by the VA's Veterans Integrated Service Network (VISN) 8 and VISN 2 to provide these critical diagnostic services to VA healthcare facilities. The VISN 8 IDC,...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract, valued at $322,400, is for the provision of cytopathology and ThyroSequence genetic testing services to support the VA's cancer screening and diagnosis programs for veterans. Cblpath, a for-profit organization specializing in cancer diagnostics, has previously provided similar...
Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded an Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 2 (VISN 2) to provide ThyroSeq molecular diagnostic testing services. The single-award IDC has a ceiling value of $1,800,000 and a period of performance through February 2026. Under this IDC, Cblpath has received two task orders to date: a $120,000 firm fixed price delivery order for ThyroSequence Testing...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a single award indefinite delivery contract to Cytopath Biology Lab Inc. to provide cytopathology and ThyroSeq testing services. Under the contract, Cytopath Biology Lab Inc. leverages its Cblpath division to conduct diagnostic pathology testing at its laboratory in Lebanon, Pennsylvania. Three firm fixed price delivery orders have been issued against the contract to date, valued at...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded an Indefinite Delivery Contract (IDC) to Cvpath Institute Inc., a non-profit organization, to provide cardiovascular pathology services in support of VA-funded research efforts. The single-award IDC has a ceiling value of $42,048 and a performance period from March 2023 to March 2026.
Under this contract, Cvpath Institute processes tissue samples, produces slides with specialized staining, and digitizes slides to aid studies aimed at improving cardiovascular care for veterans. The work is typically performed at Cvpath's location in Potomac, Maryland, and does not involve any set-aside designations. This IDC enables the VA to efficiently procure Cvpath's specialized services for ongoing and future cardiovascular research projects across multiple sites, ensuring consistent and high-quality pathology support. Cvpath Institute has provided similar services to the VA under past federal contract awards and grant subawards, leveraging its expertise in cardiovascular pathology and access to a sudden cardiac death registry to contribute to studies on severe coronary artery disease.